| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.007 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.008 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.14 | 0.009 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.094 | 0.009 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.01 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |